Compare HROW & IRDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HROW | IRDM |
|---|---|---|
| Founded | 1998 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.7B |
| IPO Year | N/A | N/A |
| Metric | HROW | IRDM |
|---|---|---|
| Price | $41.34 | $16.52 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 5 |
| Target Price | ★ $68.86 | $27.60 |
| AVG Volume (30 Days) | 716.4K | ★ 2.0M |
| Earning Date | 11-10-2025 | 10-23-2025 |
| Dividend Yield | N/A | ★ 3.65% |
| EPS Growth | N/A | ★ 22.73 |
| EPS | N/A | ★ 1.14 |
| Revenue | $250,042,000.00 | ★ $871,710,000.00 |
| Revenue This Year | $43.92 | $7.64 |
| Revenue Next Year | $41.22 | $1.70 |
| P/E Ratio | ★ N/A | $14.44 |
| Revenue Growth | ★ 47.83 | 7.30 |
| 52 Week Low | $20.85 | $15.65 |
| 52 Week High | $50.72 | $34.45 |
| Indicator | HROW | IRDM |
|---|---|---|
| Relative Strength Index (RSI) | 58.85 | 42.49 |
| Support Level | $36.95 | $15.65 |
| Resistance Level | $41.24 | $16.56 |
| Average True Range (ATR) | 2.64 | 0.45 |
| MACD | 0.52 | 0.09 |
| Stochastic Oscillator | 89.48 | 56.52 |
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
Iridium Communications Inc is the commercial provider of communications services offering true globalised coverage, connecting people, organizations and assets to and from anywhere, in real time. The company is a provider of mobile voice and data communications services through a constellation of low earth-orbiting satellites. Iridium's solutions are ideally suited for industries such as maritime, aviation, government/military, emergency/humanitarian services, mining, forestry, oil and gas, heavy equipment, transportation, and utilities. Iridium also provides service to subscribers from the U.S. Department of Defense, as well as other civil and government agencies world-wide. The Company operates in one business segment, providing satellite communications services and products.